Parallel Advisors LLC Reduces Stock Position in UnitedHealth Group Incorporated $UNH

Parallel Advisors LLC cut its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 8.6% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 28,601 shares of the healthcare conglomerate’s stock after selling 2,702 shares during the quarter. Parallel Advisors LLC’s holdings in UnitedHealth Group were worth $8,922,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in UNH. Bayforest Capital Ltd increased its holdings in shares of UnitedHealth Group by 685.7% in the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after acquiring an additional 48 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd grew its stake in UnitedHealth Group by 416.7% during the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock worth $32,000 after buying an additional 50 shares during the last quarter. Copia Wealth Management bought a new position in UnitedHealth Group during the 4th quarter worth $42,000. IAG Wealth Partners LLC bought a new position in UnitedHealth Group during the 1st quarter worth $42,000. Finally, Investment Management Corp VA ADV bought a new position in UnitedHealth Group during the 4th quarter worth $44,000. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Trading Down 0.3%

Shares of NYSE UNH opened at $352.61 on Monday. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73. The business has a fifty day simple moving average of $291.98 and a 200-day simple moving average of $368.31. The company has a market cap of $319.35 billion, a price-to-earnings ratio of 15.28, a P/E/G ratio of 2.30 and a beta of 0.45.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The firm had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. During the same period in the previous year, the company earned $6.80 earnings per share. The business’s revenue for the quarter was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be given a $2.21 dividend. The ex-dividend date is Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.5%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 38.30%.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on UNH shares. Bank of America upped their price objective on UnitedHealth Group from $290.00 to $325.00 and gave the stock a “neutral” rating in a research note on Monday, August 18th. Truist Financial increased their price target on UnitedHealth Group from $310.00 to $365.00 and gave the stock a “buy” rating in a research note on Tuesday, September 9th. Sanford C. Bernstein upped their price objective on UnitedHealth Group from $337.00 to $379.00 and gave the company an “outperform” rating in a report on Friday, September 5th. JPMorgan Chase & Co. cut their price objective on UnitedHealth Group from $418.00 to $310.00 and set an “overweight” rating for the company in a report on Wednesday, August 6th. Finally, HSBC restated a “reduce” rating and issued a $270.00 price objective (down previously from $490.00) on shares of UnitedHealth Group in a report on Wednesday, May 21st. Sixteen analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have given a Sell rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $358.95.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.